Please use a PC Browser to access Register-Tadawul
Get It
BRIEF-Amylyx Pharmaceuticals Q4 EPS USD -0.3 Vs. IBES Estimate USD -0.36
Amylyx Pharmaceuticals, Inc. AMLX | 13.85 | -1.77% |
Mar 03 (Reuters) - Amylyx Pharmaceuticals Q4 operating income USD -36.605 million vs. IBES estimate USD -40.4 million.
